JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4176
Erasca
ERAS
$5B
| $616K | ﹤0.01% |
142,890
+99,044
| +226% | +$672K |
2021 Q3
5 quarters
|
|
4177
OneSpaWorld
OSW
$2.36B
| $616K | ﹤0.01% |
66,073
+7,252
| +12% | +$68.6K |
2019 Q2
14 quarters
|
|
|
VTNR
4178
DELISTED
Vertex Energy, Inc
VTNR
| $616K | ﹤0.01% |
99,444
+69,891
| +236% | +$522K |
2022 Q2
2 quarters
|
|
4179
FS KKR Capital
FSK
$2.99B
| $615K | ﹤0.01% |
35,129
-37,421
| -52% | -$696K |
2021 Q3
5 quarters
|
|
|
KSI
4180
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
| $614K | ﹤0.01% |
61,224
-95,340
| -61% | -$947K |
2021 Q2
6 quarters
|
|
4181
CALL
Lantheus
LNTH
$6.53B
| $612K | ﹤0.01% |
12,000
+3,200
| +36% | +$197K |
2022 Q3
1 quarter
|
|
4182
Amneal Pharmaceuticals
AMRX
$7.07B
| $611K | ﹤0.01% |
307,042
-61,919
| -17% | -$139K |
2018 Q2
18 quarters
|
|
4183
Enviri
NVRI
$562M
| $611K | ﹤0.01% |
97,038
+2,745
| +3% | +$16.4K |
2013 Q2
38 quarters
|
|
4184
Aurinia Pharmaceuticals
AUPH
$2.09B
| $610K | ﹤0.01% |
141,010
+65,446
| +87% | +$380K |
2021 Q2
6 quarters
|
|
4185
Hyster-Yale Materials Handling
HY
$576M
| $606K | ﹤0.01% |
23,936
+5,767
| +32% | +$161K |
2013 Q2
38 quarters
|
|
|
BBBY
4186
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $606K | ﹤0.01% |
241,300
+149,300
| +162% | +$586K |
2022 Q2
2 quarters
|
|
4187
KRONOS Worldwide
KRO
$905M
| $605K | ﹤0.01% |
64,246
-2,237
| -3% | -$21.2K |
2017 Q4
20 quarters
|
|
4188
Lightwave Logic
LWLG
$866M
| $604K | ﹤0.01% |
140,339
+14,785
| +12% | +$105K |
2021 Q4
4 quarters
|
|
4189
DocGo
DCGO
$35.8M
| $603K | ﹤0.01% |
85,239
+40,879
| +92% | +$343K |
2022 Q2
2 quarters
|
|
|
LBC
4190
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $603K | ﹤0.01% |
54,250
-74,395
| -58% | -$874K |
2018 Q1
19 quarters
|
|
4191
PUT
BioNTech
BNTX
$24B
| $601K | ﹤0.01% |
+4,000
| New | +$616K |
2022 Q4
0 quarters
|
|
4192
Modine Manufacturing
MOD
$10.1B
| $599K | ﹤0.01% |
30,168
+2,528
| +9% | +$46.9K |
2016 Q4
24 quarters
|
|
|
OLPX
4193
DELISTED
Olaplex Holdings
OLPX
| $597K | ﹤0.01% |
114,607
-5,921
| -5% | -$35.2K |
2021 Q3
5 quarters
|
|
4194
ProShares Short QQQ
PSQ
$572M
| $596K | ﹤0.01% |
8,099
+4,402
| +119% | +$315K |
2022 Q3
1 quarter
|
|
|
COOP
4195
PUT
DELISTED
Mr. Cooper
COOP
| $594K | ﹤0.01% |
+14,800
| New | +$625K |
2022 Q4
0 quarters
|
|
4196
Rush Enterprises Class B
RUSHB
$6.6B
| $594K | ﹤0.01% |
23,731
+15,671
| +194% | +$369K |
2017 Q4
20 quarters
|
|
4197
CALL
Marvell Technology
MRVL
$258B
| $593K | ﹤0.01% |
16,000
-500,000
| -97% | -$20.4M |
2022 Q1
3 quarters
|
|
4198
Roivant Sciences
ROIV
$25.7B
| $593K | ﹤0.01% |
74,294
+33,534
| +82% | +$187K |
2022 Q2
2 quarters
|
|
4199
C4 Therapeutics
CCCC
$354M
| $592K | ﹤0.01% |
100,482
+74,117
| +281% | +$615K |
2020 Q4
8 quarters
|
|
4200
Brookdale Senior Living
BKD
$2.6B
| $591K | ﹤0.01% |
216,291
+26,318
| +14% | +$98.4K |
2013 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.